Workflow
Day One Biopharmaceuticals, Inc. (DAWN) Reports Q3 Loss, Tops Revenue Estimates
Day One Biopharmaceuticals panyDay One Biopharmaceuticals pany(US:DAWN) ZACKS·2025-11-05 07:11

Day One Biopharmaceuticals, Inc. (DAWN) came out with a quarterly loss of 0.19pershareversustheZacksConsensusEstimateofalossof0.19 per share versus the Zacks Consensus Estimate of a loss of 0.28. This compares to earnings of 0.38pershareayearago.Thesefiguresareadjustedfornon−recurringitems.Thisquarterlyreportrepresentsanearningssurpriseof+32.140.38 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +32.14%. A quarter ago, it was expected that this company would post a loss of 0.35 per share when it actually produced a loss of $0.29, delivering a surprise of +17.14%.Over the last four quarters, t ...